Résumé

Purpose: To evaluate the prevalence of glaucoma in CADESO patients and to describe its management. Methodology: This is a prospective descriptive cross-sectional study of 3 months duration from October 20, 2021 to January 19, 2022. Results: The prevalence of glaucoma was 7.9% with a male predominance (58.4%). The 60 to 69 years old age group was the most affected with an average age of 57.29 +/- 17.06 years. The frequency of POAG was 91.8%. The main treatments prescribed to the diagnosed patients were medication (90.7%), physical (8.6%) and surgical (6%). The most represented therapeutic classes were BBs (75.1%). Timolol was the most prescribed molecule (72.5%). Conclusion: The popularization of diagnostic and therapeutic means would allow the prevention/treatment of glaucoma and its complications as early as possible.

Mot-clés :

Glaucoma, Prevalence, Therapeutic Combinations, Therapeutic Classes